AIRLINK 73.18 Increased By ▲ 0.38 (0.52%)
BOP 5.00 Decreased By ▼ -0.06 (-1.19%)
CNERGY 4.37 Increased By ▲ 0.04 (0.92%)
DFML 29.95 Decreased By ▼ -0.57 (-1.87%)
DGKC 91.39 Increased By ▲ 5.44 (6.33%)
FCCL 23.15 Increased By ▲ 0.80 (3.58%)
FFBL 33.50 Increased By ▲ 0.28 (0.84%)
FFL 9.92 Increased By ▲ 0.14 (1.43%)
GGL 10.35 Decreased By ▼ -0.05 (-0.48%)
HBL 113.01 Decreased By ▼ -0.61 (-0.54%)
HUBC 136.28 Increased By ▲ 0.08 (0.06%)
HUMNL 9.60 Decreased By ▼ -0.43 (-4.29%)
KEL 4.78 Increased By ▲ 0.12 (2.58%)
KOSM 4.72 Increased By ▲ 0.32 (7.27%)
MLCF 39.89 Increased By ▲ 1.54 (4.02%)
OGDC 133.90 Increased By ▲ 0.50 (0.37%)
PAEL 28.85 Increased By ▲ 1.45 (5.29%)
PIAA 25.00 Increased By ▲ 0.24 (0.97%)
PIBTL 6.94 Increased By ▲ 0.39 (5.95%)
PPL 122.40 Increased By ▲ 1.19 (0.98%)
PRL 27.40 Increased By ▲ 0.25 (0.92%)
PTC 14.80 Increased By ▲ 0.91 (6.55%)
SEARL 60.40 No Change ▼ 0.00 (0%)
SNGP 70.29 Increased By ▲ 1.76 (2.57%)
SSGC 10.42 Increased By ▲ 0.09 (0.87%)
TELE 8.85 Decreased By ▼ -0.20 (-2.21%)
TPLP 11.32 Increased By ▲ 0.06 (0.53%)
TRG 66.57 Increased By ▲ 0.87 (1.32%)
UNITY 25.20 Decreased By ▼ -0.05 (-0.2%)
WTL 1.55 Increased By ▲ 0.05 (3.33%)
BR100 7,676 Increased By 42.9 (0.56%)
BR30 25,471 Increased By 298.6 (1.19%)
KSE100 73,086 Increased By 427.5 (0.59%)
KSE30 23,427 Increased By 44.5 (0.19%)
Markets

Wall Street ends mixed as new aid deal remains elusive

    • Nasdaq was down 0.4 percent to 10,968.36, but the Dow Jones Industrial Average gained 1.3 percent to end at 27,791.44.
Published August 11, 2020

NEW YORK: Wall Street ended Monday's trading session the way it started: mixed, with Nasdaq retreating again as investors eye uncertain data and an elusive deal on a new emergency spending package.

At the closing bell on the first trading session of the week, the tech-rich Nasdaq was down 0.4 percent to 10,968.36, but the Dow Jones Industrial Average gained 1.3 percent to end at 27,791.44 and the broad-based S&P 500 rose 0.3 percent to finish at 3,360.47.

The only data reports released Monday both offered information on the state of the pandemic-ravaged US jobs market, but one was from June, before COVID-19 cases began to resurge, taking the total past five million.

The other, the Conference Board's Employment Trends Index, showed a slight improvement in July but nonetheless confirmed the grim outlook.

The index is down 53.8 percent from a year ago, and Gad Levanon, head of The Conference Board Labor Markets Institute, warned that in coming months "job growth will significantly put on the brakes, likely causing the national unemployment rate to remain in double-digit territory."

What form a new spending package will take remained in doubt as the White House and Democratic leaders in Congress traded barbs and blaming each other for the failure to reach agreement.

President Donald Trump signed four executive orders over the weekend including one to defer payroll taxes, and another to provide $400 in weekly unemployment benefits, $100 of which will be paid by already cash-strapped states, to replace the $600 weekly payments that expired at the end of July.

Senator Chuck Schumer, the lead Democrat in the upper house of Congress, called Trump's efforts "laughable," while Treasury Secretary Steven Mnuchin called the Democratic proposal for aid to state and local governments "absurd."

But Peter Cardillo of Spartan Capital Securities told AFP: "The market is ignoring negative factors.

"It continues to move on higher on hopes of the recovery gaining traction."

McDonald's slipped 0.2 percent after the company announced it was suing former CEO Steve Easterbrook to recover compensation after discovering he lied "and destroyed information" about relationships with three other employees, and gave stock worth hundreds of thousands of dollars to one of the employees.

Marriott International missed earnings expectations but still jumped 3.6 percent on the upbeat outlook, while MGM Resorts surged nearly 14 percent after announcing a $1 billion investment.

But Kodak plunged 28 percent after a US agency suspended a loan intended to support the former photo giant's launch of a new pharmaceutical venture following controversy that has surrounded its July 28 announcement about the $765 million loan.

Comments

Comments are closed.